Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells: Some are involved in tumorigenic and metastatic properties of human melanoma cells

Immunopharmacology

Volumn 42, Issue 1-3, 1999, Pages 39-45

  Frade, Raymond ^a  

^a INSERM   (France)

Author keywords

Human C3; Melanoma; Metastasis; Proteinases; Tumorigenic

Indexed keywords

ANKYRIN; ANTIBODY; CATHEPSIN L; COMPLEMENT COMPONENT C3; CYSTEINE PROTEINASE; EPITOPE; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; CARCINOGENESIS; CARCINOGENICITY; CELL INTERACTION; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME STRUCTURE; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LUNG METASTASIS; MELANOMA CELL; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

AMINO ACID SEQUENCE; ANIMALS; COMPLEMENT C3; CYSTEINE ENDOPEPTIDASES; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; SERINE ENDOPEPTIDASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032995420     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00028-4     Document Type: Conference Paper

References (37)

1. Adenis A., Huet G., Zerimech F., Hecquet B., Balduyck M., Peyrat J.P. Cathepsin B, L and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Cancer Lett. 96:1995;267-275.
2. Ahearn J.M., Fearon D.T. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:1989;183-219.
3. Charriaut-Marlangue C., Barel M., Frade R. Identification of p57, a serine proteinase, from human erythrocyte membranes, which cleaves both chains of human third component (C3) of complement. Biochem. Biophys. Res. Commun. 140:1986;1113-1120.
4. Chauhan S.S., Goldstein L.J., Gottesman M.M. Expression of cathepsin L in human tumors. Cancer Res. 51:1991;1478-1481.
5. Erdei A., Fust G., Gergely J. The role of C3 in the immune response. Immunol. Today. 12:1991;332-337.
6. Ferluga J., Schorlemmer H.U., Baptista L.C., Allison A.C. Production of the complement cleavage product, C3a by activated macrophages and its tumorolytic effects. Clin. Exp. Immunol. 31:1978;512-517.
7. Frade R., Myones B.L., Barel M., Krikorian L., Charriaut C., Ross G.D. Gp140, a C3b binding membrane component of B lymphocytes is the C3d/C3dg receptor (CR2) and is distinct from the neutrophils C3dg receptor (CR4). Eur. J. Immunol. 15:1985;1192-1197.
8. Frade R., Rodrigues-Lima F., Huang S., Xie K., Guillaume N., Bar-Eli M. Procathepsin-L, a proteinase that cleaves human C3, the third component of complement, confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res. 58:1998;2733-2736.
9. Gal S., Gottesman M.M. Isolation and sequence of cDNA for human pro-cathepsin L. Biochem. J. 253:1988;303-306.
10. Gergely J., Erdei A., Sarmay G., Klein E. Effector on target cell selection mediated by C3 bridge. Immunol. Lett. 14:1987;243-248.
11. Hermann J., Barel M., Frade R. Human erythrocyte ankyrin, a cytoskeleton component generates the p57 membrane proteinase which cleaves C3, the third component of complement. Biochem. Biophys. Res. Commun. 204:1994;453-460.
12. Hiedtmann H.H., Salge U., Havemann K., Kirschke H., Wiederanders B. Secretion of latent, acid-activable cathepsin-L precursor by human non-small cell lung cancer cell lines. Oncology Res. 5:1993;441-451.
13. Jean D., Hermann J., Rodrigues-Lima F., Barel M., Balbo M., Frade R. Identification on melanoma cells of p39, a cysteine proteinase which cleaves C3, the third component of complement: amino acid sequence identities with procathepsin L. Biochem. J. 312:1995;961-969.
14. Jean D., Bar-Eli M., Huang S., Xie K., Rodrigues-Lima F., Hermann J., Frade R. A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res. 56:1996;254-258.
15. Jean D., Rodrigues-Lima F., Cassinat B., Hermann J., Cabane J., Frade R. Co-expression and secretion of C3, the third component of complement and a C3-cleaving cysteine proteinase in a highly metastatic human melanoma cell line. Immunology Lett. 58:1997;107-112.
16. Lambert S., Yu H., Prchal J.T., Lawler J., Ruff P., Speicher D., Cheung M.C., Kan Y.W., Palek J. cDNA sequence for human erythrocyte ankyrin. Proc. Natl. Acad. Sci. USA. 87:1990;1730-1734.
17. Lux S.E., John K.M., Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature. 344:1990;36-42.
18. Maciewicz R.A., Wardale R.J., Etherington D.J., Paraskeva C. Immunodetection of cathepsin B and L present in and secreted from human pre-malignant and malignant colorectal tumor cell lines. Int. J. Cancer. 43:1989;478-486.
19. Maison C.M., Villiers C.L., Colomb M.G. Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937. Biochem. J. 261:1989;407-413.
20. Mason R.W., Green G.D.J., Barrett A.J. Human liver cathepsin L. Biochem. J. 226:1985;233-241.
21. Müller-Eberhard H.J., Schreiber R.D. Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol. 29:1980;1-53.
22. Nishida Y., Kohno K., Kawamata T., Morimitsu K., Kuwano M., Miyakawa I. Increased cathepsin-L levels in serum in some patients with ovarian cancer: comparaison with CA125 and CA72-4. Gynecol. Oncol. 56:1995;357-361.
23. Ollert M.W., Frade R., Fiandino A., Panneerselvam M., Petrella E.C., Barel M., Pangburn M.K., Bredehorst R., Vogel C.W. C3-cleaving proteinase: a new complement regulatory protein of human melanoma cells. J. Immunol. 144:1990;3862-3867.
24. Parck I.C., Lee S.Y., Jeon D.G., Lee J.S., Hwang C.S., Hwang B.G., Lee S.H., Hong W.S., Hong S.I. Enhanced expression of cathepsin-L in metastatic bone tumors. J. Korean Med. Sci. 11:1996;144-148.
25. Perlmutter D.H., Glover G.I., Rivetna M., Schasteen C.S., Fallon R.J. Identification of a serpin-enzyme complex receptor on human hepatoma eclls and human monocytes. Proc. Natl. Acad. Sci. USA. 87:1990;3753-3757.
26. Ramos O.F., Algarra I., Sarmay G., Yefenof E., Gergely J., Klein E. Lymphocytes stimulated by allogenic B cell lines cleave the third component of complement and fix C3 fragments. their nonspecific lytic capacity is elevated against complement receptor type2-carrying targets. J. Immunol. 142:1989;217-223.
27. Rey-Millet C.A., Chesne S., Colomb M.G. Associated complement C3b. Towards an understanding of its intracellular modifications. Mol. Immunol. 30:1993;855-864.
28. Rey-Millet C.A., Villiers C.L., Gabert F.M., Chesne S., Colomb M.G. C3b covalently associated to tetanus toxin modulates TT processing and presentation by U937 cells. Mol. Immunol. 31:1994;1321-1327.
29. Rodrigues-Lima, R., 1998. Study of the structure and the function of proteinases which cleave human C3: role of cysteine proteinase in tumorigenic and metastatic properties of human melanoma cells. PhD thesis, University of Paris VII, October.
30. Rodrigues-Lima F., Hermann J., Jean D., Frade R. α1-proteinase inhibitor is the serum regulator of the activity of p57, a C3-cleaving proteinase present in human erythrocyte membranes. Biochem. Biophys. Acta. 1402:1998;131-138.
31. Rozhin J., Wade R.L., Honn K.V., Sloane B.F. Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochem. Biophys. Res. Commun. 164:1989;556-561.
32. Santamaria I., Velasco G., Carzola M., Fueyo A., Campo E., Lopez-Otin C. Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res. 58:1998;1624-1630.
33. Smith S.M., Gottesman M.M. Activity and deletion analysis of recombinant human cathepsine-L expressed in Escherichia coli. J. Biol. Chem. 264:1989;20487-20495.
34. Thomssen C., Schmitt M., Goretzki L., Oppelt P., Pache L., Dettmar P., Jänicke F., Graeff H. Prognostic values of the cysteine proteases cathepsin B and cathepsin L in human breast cancer. Clin. Cancer Res. 1:1995;741-746.
35. Weaver D.C., Pasternack G.R., Marchesi V.T. The structural basis of ankyrin function. II. Identification of two functional domains. J. Biol. Chem. 259:1984;6170-6175.
36. Xie S., Luca M., Huang S., Gutman S., Reich R., Johnson J.P., Bar-Eli M. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 57:1997;2295-2303.
37. Zhang R.D., Price J.E., Schackert G., Itoh K., Fidler I.J. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis. Cancer Res. 51:1991;2029-2035.